Towards Healthcare
Antacids Market Size | Trends | Growth Rate (2023 - 2032)

Antacids Market Size to Hit USD 9.64 Billion by 2032

The report covers Antacids Market Size and Companies segmented by formulation type, indication and distribution channels. Formulation types include tablets, liquids and other variants, catering to different consumer preferences and needs. Indications for antacids span from gastroesophageal reflux disease (GERD) and heartburn to indigestion and other related gastrointestinal issues. These products are distributed through various channels including hospital pharmacies, drug stores, retail pharmacies and online providers. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Antacids Market Assessment

  • Overview
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider
  • Global Antacids Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa

North America Antacids Market Assessment

  • Overview
  • North America Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • North America Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • North America Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Europe Antacids Market Assessment

  • Overview
  • Europe Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Europe Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Europe Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Asia-Pacific Antacids Market Assessment

  • Overview
  • Asia-Pacific Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Asia-Pacific Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Asia-Pacific Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Latin America Antacids Market Assessment

  • Overview
  • Latin America Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Latin America Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Latin America Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Middle East and Africa Antacids Market Assessment

  • Overview
  • Middle East and Africa Antacids Market Size Value (US$) and Volume (Billion Tons), by Formulation Type (2021 – 2033)
    • Tablet
    • Liquid
    • Other
  • Middle East and Africa Antacids Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Gastroesophageal Reflux Disease
    • Heartburn
    • Indigestion
    • Others
  • Middle East and Africa Antacids Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Drug Store and Retail Pharmacy
    • Online Provider

Company Profiles

  • Bayer AG
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • GlaxoSmithKline Plc.
  • Takeda Pharmaceutical Company Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr Reddy's Laboratories Ltd.
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc.
  • Cipla Ltd.
  • Alkem Laboratories Ltd.
  • Abbott Laboratories

Conclusion & Recommendations

  • Insight Code: 5079
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: December 2023
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

The rise is attributed to factors like dietary habits and lifestyle changes. Consequently, the antacid market has grown is due prevalence of diseases to meet the increasing demand for treating the symptoms of acid reflux. The Aging Population is also responsible for Driving Demand for Antacids.

The major key players operating in the antacid market are Bayer AG, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Ltd., Sun Pharmaceutical Industries Ltd., Dr Reddys Laboratories Ltd., Pfizer Inc., Reckitt Benckiser Group Plc., Cipla Ltd., Alkem Laboratories Ltd., and Abbott Laboratories.

North America and Asia-Pacific are the leading region for the Global Antacid Market.

National Institute of Health, World Health Organisation, Centers for Disease Control and Prevention, American Journal of Health-System Pharmacy, USDA | Economical Research Services, ScienceDirect, Wolters Kluwer, MedlinePlus(.gov), International Journal of Research in Medical Sciences

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509